What have we learnt from targeted anti-TNF therapy? | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article info

Papers

Supplement

What have we learnt from targeted anti-TNF therapy?

Authors

M Feldmann PubMed articles Google scholar articles
R O Williams PubMed articles Google scholar articles
E Paleolog PubMed articles Google scholar articles

Correspondence to Professor M Feldmann, Kennedy Institute of Rheumatology Division, Imperial College, 65 Aspenlea Road, London W6 8LH, UK; m.feldmann{at}imperial.ac.uk

Citation

Feldmann M, Williams RO, Paleolog E

What have we learnt from targeted anti-TNF therapy?

Annals of the Rheumatic Diseases 2010;69:i97-i99.

Publication history

Accepted June 23, 2009
First published December 7, 2009.

Online issue publication

December 07, 2009

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

BMJ Publishing Group Ltd and European League Against Rheumatism. All rights reserved.